152 related articles for article (PubMed ID: 31646080)
1. Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin.
Ibáñez-Pérez R; Guerrero-Ochoa P; Al-Wasaby S; Navarro R; Tapia-Galisteo A; De Miguel D; Gonzalo O; Conde B; Martínez-Lostao L; Hurtado-Guerrero R; Sanz L; Anel A
Oncoimmunology; 2019; 8(11):1641392. PubMed ID: 31646080
[TBL] [Abstract][Full Text] [Related]
2. Production of a Granulysin-Based, Tn-Targeted Cytolytic Immunotoxin Using Pulsed Electric Field Technology.
Guerrero-Ochoa P; Aguilar-Machado D; Ibáñez-Pérez R; Macías-León J; Hurtado-Guerrero R; Raso J; Anel A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859066
[TBL] [Abstract][Full Text] [Related]
3.
Al-Wasaby S; de Miguel D; Aporta A; Naval J; Conde B; Martínez-Lostao L; Anel A
Oncoimmunology; 2015 Sep; 4(9):e1036213. PubMed ID: 26405603
[TBL] [Abstract][Full Text] [Related]
4. In vivo potential of recombinant granulysin against human melanoma.
Al-Wasaby S; Guerrero-Ochoa P; Ibáñez-Pérez R; Soler R; Conde B; Martínez-Lostao L; Anel A
Cancer Treat Res Commun; 2021; 27():100355. PubMed ID: 33770663
[TBL] [Abstract][Full Text] [Related]
5. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
[TBL] [Abstract][Full Text] [Related]
6. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of recombinant 9 and 15 kDa granulysin by fed-batch fermentation in Pichia pastoris.
Guo Y; Luan G; Shen G; Wu L; Jia H; Zhong Y; Li R; Li G; Shen Y; Sun J; Hu S; Xiao W
Appl Microbiol Biotechnol; 2013 Sep; 97(17):7669-77. PubMed ID: 23224405
[TBL] [Abstract][Full Text] [Related]
8. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y; Okada M; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Takamori Y; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
[TBL] [Abstract][Full Text] [Related]
9. Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors.
Aporta A; Catalán E; Galán-Malo P; Ramírez-Labrada A; Pérez M; Azaceta G; Palomera L; Naval J; Marzo I; Pardo J; Anel A
Biochem Pharmacol; 2014 Feb; 87(3):410-23. PubMed ID: 24269628
[TBL] [Abstract][Full Text] [Related]
10. Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma.
Zhang J; Liu YF; Yang SJ; Qiao Q; Cheng H; Zhang CS; Ma FC; Guo HZ
World J Gastroenterol; 2004 Jul; 10(13):1872-5. PubMed ID: 15222026
[TBL] [Abstract][Full Text] [Related]
11. Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo.
Schirrmann T; Pecher G
Cancer Gene Ther; 2002 Apr; 9(4):390-8. PubMed ID: 11960290
[TBL] [Abstract][Full Text] [Related]
12. Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.
Darcy PK; Haynes NM; Snook MB; Trapani JA; Cerruti L; Jane SM; Smyth MJ
J Immunol; 2000 Apr; 164(7):3705-12. PubMed ID: 10725729
[TBL] [Abstract][Full Text] [Related]
13. Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30
Hombach AA; Rappl G; Abken H
Mol Ther; 2019 Oct; 27(10):1825-1835. PubMed ID: 31331813
[TBL] [Abstract][Full Text] [Related]
14. Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.
Kioi M; Seetharam S; Puri RK
Mol Cancer Ther; 2008 Jun; 7(6):1579-87. PubMed ID: 18566228
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.
Wang Z; Choice E; Kaspar A; Hanson D; Okada S; Lyu SC; Krensky AM; Clayberger C
J Immunol; 2000 Aug; 165(3):1486-90. PubMed ID: 10903754
[TBL] [Abstract][Full Text] [Related]
16. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
[TBL] [Abstract][Full Text] [Related]
17. Immuno-PET Imaging and Pharmacokinetics of an Anti-CEA scFv-based Trimerbody and Its Monomeric Counterpart in Human Gastric Carcinoma-Bearing Mice.
Rios X; Compte M; Gómez-Vallejo V; Cossío U; Baz Z; Morcillo MÁ; Ramos-Cabrer P; Alvarez-Vallina L; Llop J
Mol Pharm; 2019 Mar; 16(3):1025-1035. PubMed ID: 30726099
[TBL] [Abstract][Full Text] [Related]
18. Recombinant anti-human epidermal growth factor receptor type 2 single-chain variable fragment-alpha-luffin fusion protein as a putative immunotoxin against human epidermal growth factor receptor type 2-positive breast cancer cells: an experimental research.
Damough S; Bayat E; Oghabi Bakhshaiesh T; Barkhordari F; Esmaeili R; Nematollahi L; Talebkhan Y
Ann Med Surg (Lond); 2023 Sep; 85(9):4348-4354. PubMed ID: 37663730
[TBL] [Abstract][Full Text] [Related]
19. Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts.
Tomé-Amat J; Olombrada M; Ruiz-de-la-Herrán J; Pérez-Gómez E; Andradas C; Sánchez C; Martínez L; Martínez-Del-Pozo Á; Gavilanes JG; Lacadena J
Springerplus; 2015; 4():168. PubMed ID: 25883890
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Reiter Y; Pai LH; Brinkmann U; Wang QC; Pastan I
Cancer Res; 1994 May; 54(10):2714-8. PubMed ID: 8168102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
